Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dover Corp (DOV) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Dover CorpTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Dover Corp vs Vir Biotechnology Inc. Common Stock — how do they compare? Dover Corp trades at $193.04 (market cap $25.92B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Dover Corp is far larger — about 14.4× Vir Biotechnology Inc. Common Stock's market cap, and Dover Corp pays a 1.09% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 74 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

DOVVIR
Market Cap
$25.92B$1.80B
Volume
807,4521,782,836
Sector
IndustrialsHealth
52-Week High
$233.31$11.78
52-Week Low
$162.66$5.12
Typical Hold Time
74 Days0 Days
Enterprise Value
$27.43B$1.36B
Dividend Yield
1.09%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dover Corp

Dover Corporation (DOV) trades at $193.33, up 1.28% with strong analyst consensus of 19 Buy ratings and no Sell recommendations. The stock shows solid fundamentals with consistent earnings beats, 13.48% net margin, and robust cash flow. Recent acquisitions and product launches position the company for growth, while technical indicators suggest neutral momentum near key resistance at $195.

Outlook remains positive with 67.9% analyst Buy rating and $243.20 price target representing 26% upside. Risks include integration challenges from recent acquisitions and industrial sector volatility. The company's Dividend King status and strong balance sheet provide stability amid market fluctuations.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOV

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Dover Corp

Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.

Read more on DOV →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →